Xtx Topco LTD Insmed Inc Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $861,620 - $1 Million	33,500 New	33,500 $908,000
Q3 2023 Nov 13, 2023	BUY	$19.86 - $26.93 $185,234 - $251,176	9,327 New	9,327 $235,000
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $175,131 - $238,769	10,314 New	10,314 $206,000
Q4 2021 Feb 11, 2022	SELL	$25.89 - $33.45 $325,204 - $420,165	-12,561 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $282,120 - $370,172	12,561 New	12,561 $346,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.